These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6461194)

  • 41. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiarrhythmic effects of stirocainide in acute myocardial infarction.
    Gülker H; Bender F; Thale J; Heuer H; Kristek J; Hübner G; Dorsel T; Schmidt J
    Arzneimittelforschung; 1984; 34(5):559-62. PubMed ID: 6540572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
    Bergey JL; Sulkowski T; Much DR; Wendt RL
    Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The influence of a new antiarrhythmic drug, Craviten (M-71) on coronary flow.
    Banaszkiewicz W; Chodera A
    Pol J Pharmacol Pharm; 1980; 32(6):849-53. PubMed ID: 6787574
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects and mechanism of action of trimazosin on coronary and left ventricular dynamics in conscious dogs.
    Macho P; Vatner SF
    J Pharmacol Exp Ther; 1981 May; 217(2):333-9. PubMed ID: 7229975
    [No Abstract]   [Full Text] [Related]  

  • 46. [The effects of non-depolarizing neuromuscular blocking agents on the cardiac contractility and cardiovascular system (author's transl)].
    Matsukawa S
    Masui; 1980 Jul; 29(7):648-56. PubMed ID: 7411843
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effects of morphine and pethidine on cardiovascular and myocardial functions in dogs (author's transl)].
    Nozaki H; Minoguchi Y; Kou S; Okuaki A
    Masui; 1980 Nov; 29(12):1470-5. PubMed ID: 7463706
    [No Abstract]   [Full Text] [Related]  

  • 48. Suppression of calcium-induced repolarization heterogeneity as a mechanism of nitroglycerin's antiarrhythmic action.
    Zhao SX; Lee LM; Nearing BD; Busso VO; Kwaku KF; Verrier RL
    J Cardiovasc Pharmacol; 2006 Aug; 48(2):22-9. PubMed ID: 16954817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of controlled hypotension on coronary and systemic hemodynamics and myocardial contractility (author's transl)].
    Konno K
    Masui; 1980 Apr; 29(4):325-35. PubMed ID: 7382100
    [No Abstract]   [Full Text] [Related]  

  • 50. Antiarrhythmic and hemodynamic responses to adenosine triphosphate during infusion of epinephrine in dogs anesthetized with halothane.
    Sohn YZ; Hong JC; Katz RL
    Anesth Analg; 1982 May; 61(5):423-9. PubMed ID: 7199866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of negative inotropic and antiarrhythmic effects of class 1 antiarrhythmic drugs.
    Nawada T; Tanaka Y; Hirai S; Hisatome I; Hasegawa J; Kotake H; Mashiba H
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):347-55. PubMed ID: 7952796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of amiodarone on the extrasystolic and post-extrasystolic contractions of the isolated myocardium of rats and of patients with chronic ischemic heart disease].
    Afanas'ev SA; Naryzhnaia NV; Lukavskaia IA; Antonchenko IV; Popov SV; Kozlov BN; Kandinskiĭ ML; Shipulin VM
    Eksp Klin Farmakol; 2003; 66(6):24-8. PubMed ID: 14743706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cardiodepressive action of anti-arrhythmia preparations].
    Gavrisiuk VK; Bugaĭ LV
    Sov Med; 1980; (9):107-8. PubMed ID: 7423250
    [No Abstract]   [Full Text] [Related]  

  • 54. A possible involvement of sodium channel blockade of class-I-type antiarrhythmic agents in postischemic contractile recovery of isolated, perfused hearts.
    Takeo S; Tanonaka K; Hayashi M; Yamamoto K; Liu JX; Kamiyama T; Yamaguchi N; Miura A; Natsukawa T
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1403-9. PubMed ID: 7791114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiarrhythmic drug effects on left ventricular performance.
    Bourke JP; Cowan JC; Tansuphaswadikul S; Campbell RW
    Eur Heart J; 1987 Mar; 8 Suppl A():105-11. PubMed ID: 3556172
    [No Abstract]   [Full Text] [Related]  

  • 56. Antiarrhythmic, antifibrillatory activities and reduction of infarct size after the calcium antagonist Ro 11-1781 (tiapamil) in anesthetized dogs.
    Saini RK; Antonaccio MJ
    J Pharmacol Exp Ther; 1982 Apr; 221(1):29-36. PubMed ID: 7062289
    [No Abstract]   [Full Text] [Related]  

  • 57. [The effect of intravenous lidocaine on myocardial contractility during halothane anesthesia in man--a study by non-invasive measurement of left ventricular systolic time intervals (author's transl)].
    Yamaoka H
    Masui; 1981 Jan; 30(1):14-9. PubMed ID: 7218506
    [No Abstract]   [Full Text] [Related]  

  • 58. [Present classification of anti-arrhythmia agents].
    Hashimoto K
    Nihon Rinsho; 1985 Nov; 43(11):2243-7. PubMed ID: 4087403
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effects of temperature changes on catecholamine-induced responses of the isolated dog atrium (author's transl)].
    Chiba S; Furukawa Y; Iwatsuki K
    Kokyu To Junkan; 1981 Jul; 29(7):703-6. PubMed ID: 7291737
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of mexiletine on the excitability and vulnerability of the dog ventricle (author's transl)].
    Márquez Montes J; Vera Almazán A; Esteve Alderete JJ; Puente Rodero B; Montero C; Castillo-Olivares JL
    Arch Farmacol Toxicol; 1981 Dec; 7(3):307-18. PubMed ID: 7337470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.